Clin2
NCT05656664Possibly a fitEnrolling by invitation

Folic acid to reduce effects of arsenic exposure

Arsenic and/or Arsenic Compound Adverse Reaction

Treatments studied

This study tests whether taking folic acid can help reduce health effects from arsenic exposure in people living near a Superfund site. You would be enrolled only if you meet safety rules, including not being pregnant and not already taking folic acid.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • Be at least 18 years old
  • Live in the Superfund area for this study
  • Have been medically stable with no major health changes in the last 4 weeks
  • Be able and willing to sign informed consent paperwork
  • Not be pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06670222Recruiting· Phase 1
Arsenic for low-risk MDS

This study tests an oral form of arsenic in people with low-risk myelodysplastic syndromes (MDS) who need regular red blood cell transfusions and haven't gotten enough benefit from standard treatments. It aims to see if this drug can help reduce transfusion needs.

Nice
NCT06778187Recruiting· Phase 2
Oral arsenic therapy for TP53-mutated blood cancers

This trial tests a combination of oral medications, including arsenic trioxide, venetoclax, and a chemotherapy agent (azacitidine or decitabine), for people with certain blood cancers (AML, MDS, or CMML) that have a TP53 gene mutation. The goal is to see if this pill-based treatment can help control the cancer.

Hong Kong
NCT07630506Recruiting· Phase 2
Folinic Acid for Autism in Children Ages 3–10

This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.

Singapore, Singapore
NCT05408247Recruiting· Phase 4
N-acetylcysteine to help people cut back on alcohol

This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.

Sydney, New South Wales
NCT01409161Recruiting· Phase 2
Tretinoin and arsenic drugs for newly diagnosed acute promyelocytic leukemia

This trial studies how well a combination of tretinoin (ATRA) and arsenic trioxide (ATO)—with or without another antibody-like drug called gemtuzumab—treats people with newly diagnosed acute promyelocytic leukemia (APL). The goal is to see if these medicines work better together and are safe.

Houston, Texas
NCT07642661Recruiting· Phase 2
Folinic Acid for Autism in Young Children

This study tests whether folinic acid (a B-vitamin supplement) can help improve autism symptoms in children ages 3–6. Folinic acid may support brain function, and researchers want to see if it works better than placebo (a dummy pill).

Jerusalem, N/A = Not Applicable

Hear when a new Arsenic and/or Arsenic Compound Adverse Reaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.